FDA Approved: ARFORMOTEROL TARTRATE INHALATION — Original Application (Devatis, Inc.)

View source ↗

Summary

FDA approved the original application for arformoterol tartrate inhalation by Devatis, Inc., a generic inhalation product for maintenance treatment of chronic o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Arformoterol tartrate inhalation (arformoterol tartrate inhalation)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE INHALATION (ARFORMOTEROL TARTRATE INHALATION)